Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;46(5):1931-1940.
doi: 10.1007/s00261-020-02857-0. Epub 2020 Nov 19.

Non-invasive assessment of cirrhosis using multiphasic dual-energy CT iodine maps: correlation with model for end-stage liver disease score

Affiliations

Non-invasive assessment of cirrhosis using multiphasic dual-energy CT iodine maps: correlation with model for end-stage liver disease score

Domenico Mastrodicasa et al. Abdom Radiol (NY). 2021 May.

Abstract

Purpose: To determine whether multiphasic dual-energy (DE) CT iodine quantitation correlates with the severity of chronic liver disease.

Methods: We retrospectively included 40 cirrhotic and 28 non-cirrhotic patients who underwent a multiphasic liver protocol DECT. All three phases (arterial, portal venous (PVP), and equilibrium) were performed in DE mode. Iodine (I) values (mg I/ml) were obtained by placing regions of interest in the liver, aorta, common hepatic artery, and portal vein (PV). Iodine slopes (λ) were calculated as follows: (Iequilibrium-Iarterial)/time and (Iequilibrium-IPVP)/time. Spearman correlations between λ and MELD scores were evaluated, and the area under the curve of the receiver operating characteristic (AUROC) was calculated to distinguish cirrhotic and non-cirrhotic patients.

Results: Cirrhotic and non-cirrhotic patients had significantly different λequilibrium-arterial [IQR] for the caudate (λ = 2.08 [1.39-2.98] vs 1.46 [0.76-1.93], P = 0.007), left (λ = 2.05 [1.50-2.76] vs 1.51 [0.59-1.90], P = 0.002) and right lobes (λ = 1.72 [1.12-2.50] vs 1.13 [0.41-0.43], P = 0.003) and for the PV (λ = 3.15 [2.20-5.00] vs 2.29 [0.85-2.71], P = 0.001). λequilibrium-PVP were significantly different for the right (λ = 0.11 [- 0.45-1.03] vs - 0.44 [- 0.83-0.12], P = 0.045) and left lobe (λ = 0.30 [- 0.25-0.98] vs - 0.10 [- 0.35-0.24], P = 0.001). Significant positive correlations were found between MELD scores and λequilibrium-arterial for the caudate lobe (ρ = 0.34, P = 0.004) and λequilibrium-PVP for the caudate (ρ = 0.26, P = 0.028) and right lobe (ρ = 0.33, P = 0.007). AUROC in distinguishing cirrhotic and non-cirrhotic patients were 0.72 (P = 0.002), 0.71 (P = 0.003), and 0.75 (P = 0.001) using λequilibrium-arterial for the left lobe, right lobe, and PV, respectively. The λequilibrium-PVP AUROC of the right lobe was 0.73 (P = 0.001).

Conclusion: Multiphasic DECT iodine quantitation over time is significantly different between cirrhotic and non-cirrhotic patients, correlates with the MELD score, and it could potentially serve as a non-invasive measure of cirrhosis and disease severity with acceptable diagnostic accuracy.

Keywords: Chronic liver disease; Dual-energy CT; Iodine concentration; Liver cirrhosis; Material decomposition.

PubMed Disclaimer

Conflict of interest statement

Compliance with ethical standards

Conflict of interest DM is supported in part by a grant from National Institute of Biomedical Imaging and Bioengineering (5T32EB009035). Activities not related to the present article: shareholder of Segmed, Inc and consultant for Segmed, Inc. MW Activities related to the present article: none. Activities not related to the present article: research grants from American Heart Association (18POST34030192), Philips Healthcare, and Stanford University, consulting for Arterys, Inc, and co-founder/shareholder of Segmed, Inc. Other relationships: no relevant relationships. BP receives research grant from General Electric. The other authors have no conflict of interest to disclose.

Figures

Fig. 1
Fig. 1
Study flowchart. DECT dual-energy CT
Fig. 2
Fig. 2
Axial contrast-enhanced dual-energy iodine maps in a patient with chronic liver disease. The iodine measurements of the liver parenchyma were performed in the arterial (a + d), portal venous (b + e), and equilibrium phase (c + f). The liver ROIs were placed on two slices, above (upper row) and below (lower row) the level of the hepatic hilum, respectively, while avoiding major vessels, bile ducts, focal lesions, and artifacts. Iodine density (mg I/ml) was measured also in the aorta, common hepatic artery, and portal vein
Fig. 3
Fig. 3
Scatterplots indicating a significant correlation (all P < 0.05) in patients with cirrhosis between MELD scores and the iodine slopes (λ) on the arterial phase for the caudate lobe and on the portal venous phase for the caudate and right lobes
Fig. 4
Fig. 4
Diagnostic performance of iodine slopes (λ) in predicting the presence of cirrhosis in patients with chronic liver disease

Similar articles

Cited by

References

    1. Tsochatzis EA, Bosch J, Burroughs AK (2014) Liver cirrhosis. Lancet 383 (9930):1749–1761. 10.1016/S0140-6736(14)60121-5 - DOI - PubMed
    1. Asrani SK, Devarbhavi H, Eaton J, Kamath PS (2019) Burden of liver diseases in the world. J Hepatol 70 (1):151–171. 10.1016/S0140-6736(14)60121-5 - DOI - PubMed
    1. Szymczak A, Simon K, Inglot M, Gladysz A (2012) Safety and effectiveness of blind percutaneous liver biopsy: analysis of 1412 procedures. Hepat Mon 12 (1):32–37. 10.5812/kowsar.1735143x.4388 - DOI - PMC - PubMed
    1. Chang Y, Kim JI, Lee B, Kim SG, Jung MJ, Kim YS, Jeong SW, Jang JY, Yoo JJ (2020) Clinical application of ultrasonography-guided percutaneous liver biopsy and its safety over 18 years. Clin Mol Hepatol 26 (3):318–327. 10.3350/cmh.2019.0019n - DOI - PMC - PubMed
    1. Wong VW, Adams LA, de Ledinghen V, Wong GL, Sookoian S (2018) Noninvasive biomarkers in NAFLD and NASH - current progress and future promise. Nat Rev Gastroenterol Hepatol 15 (8):461–478. 10.1038/s41575-018-0014-9 - DOI - PubMed

LinkOut - more resources